StockNews.com Begins Coverage on CASI Pharmaceuticals (NASDAQ:CASI)
Investment analysts at StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report) in a report issued on Sunday. The firm set a “hold” rating on the biotechnology company’s stock. CASI Pharmaceuticals Stock Performance Shares of CASI Pharmaceuticals stock opened at $2.47 on Friday. The company has a market capitalization of $38.33 […]
